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Background Alcohol use is a common problem in bipolar disorder (BD) and evidence 
indicates more promising outcomes for alcohol use than other substances.  No trials have 
evaluated individual integrated motivational interviewing and cognitive behaviour therapy 
(MI-CBT) for problematic alcohol use in BD. We therefore assessed the feasibility and 
acceptability of a novel MI-CBT intervention for alcohol use in BD. 
Methods A single blind RCT was conducted to compare MI-CBT plus treatment as usual 
(TAU) with TAU only. MI-CBT was delivered over 20 sessions with participants followed at 
3, 6, 9 and 12 months post-randomisation. Primary outcomes were the feasibility and 
acceptability of MI-CBT (recruitment to target, retention to follow-up, absence of untoward 
incidents). We also conducted preliminary analyses of alcohol and mood outcomes 
(frequency and severity of alcohol use and time to mood relapse). 
Results 44 participants were recruited with 75% retention to 6 and 12 months follow-up. 
Therapy participants attended a mean of 17.6 (SD 4.5) sessions. Therapy alliance and 
treatment fidelity were acceptable. Qualitative interviews indicated the intervention was 
experienced as collaborative, and helpful, in addressing mood and alcohol issues, although 
risk of overconfidence following therapy was also identified. Clinical outcomes did not differ 
between arms at 12 months follow-up.  
Limitations As a feasibility and acceptability trial any secondary results should be treated 
with caution.  
Conclusions Integrated MI-CBT intervention is feasible and acceptable, but lack of clinical 
impact, albeit in a feasibility study, suggests need for further development. Potential 
adaptations are discussed.  
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Background  
Substance use in bipolar disorder (BD) has a lifetime prevalence rate ranging from 50-60% 
for bipolar 1 and 37-40% for bipolar II disorder (Merikangas et al., 2007; 2011), and is 
associated with worse outcome including poorer functioning (Cardoso et al., 2008; Marshall 
et al., 2012; Mazza et al., 2009), clinical course (Gaudiano et al., 2008; Rakofsky & Dunlop, 
2013) and treatment response (Frye & Salloum, 2006; van Zaane et al., 2010) in both groups..  
Alcohol is the most commonly abused substance in BD (Merikangas et al., 2011), and is 
associated with worse clinical course and outcomes, including more severe mood disturbance 
(Goldstein et al., 2006), impulsivity (Alloy et al., 2009; Etain et al., 2013; Henna et al., 2013; 
Swann et al., 2007), suicide (Cardoso, et al., 2008; Bellivier et al., 2011; Oquendo et al., 
2010), violence and relapse (Elbogen & Johnson, 2009). 
4 
 
Most psychological interventions research in bipolar has focused on evaluating the 
effectiveness of cognitive behaviour therapy or psychoeducation interventions intended to 
reduce relapse of mood episodes (Lam et al.,2003; Scott et al., 2006). However these 
approaches do not address substance use issues and there have been few developments in 
integrated therapy to tackle substance use problems in BD. Schmitz et al. (2002) observed no 
differences between 12 weeks of individual cognitive behavioural therapy (CBT) vs 
medication monitoring on substance use outcomes but some improvement in mood. Weiss 
and colleagues (2007; 2009) conducted two randomised controlled trials (RCTs) evaluations 
of integrated group therapy (IGT) compared with group counselling. . IGT consists of 12 
weekly sessions based on CBT principles to address bipolar and substance use issues.  IGT 
led to improvements in substance abuse outcomes, particularly alcohol use. However, mood 
outcomes were more mixed; one trial indicated worsening of mood symptoms, the other 
improved overall clinical outcomes (Weiss etal., 2007; 2009). Gold and colleagues (2018) 
identified a further 4 trials of which one was an RCT targeting substance use in BD 
(interventions included family focused therapy, acceptance and commitment therapy, CBT 
and Treatment adherence therapy). None had a specific effect on substance use outcomes 
although two pilot/open trials indicated possible benefits of CBT/Acceptance and 
Commitment therapy in addressing smoking cessation in BD (Heffner et al., 2013; 2015) 
Given the very mixed outcomes from the limited literature to date, for the current study we 
have integrated motivational interviewing (MI) with CBT approaches for BD. The addition of 
MI is important omission, as ambivalence to treatment is common in BD (Liebert, 2013; 
Weiss et al., 1999) and there is evidence for MI addressing both treatment ambivalence 
(Miller & Rollnick, 2002) and alcohol and drug issues (Burke et al., 2003; Match, 1997). We 
have shown previously that integrating MI with CBT for substance use in BD was feasible in 
a case series of treatment ambivalent individuals with problems with alcohol or cannabis use 
(Jones et al., 2011). The current report describes the application and evaluation of a therapy 
approach for addressing alcohol use in BD that integrated MI approaches to engage clients 
and achieve commitment to change with CBT approaches to provide tools for change and 
relapse prevention (MI-CBT). We report the valuation through a RCT feasibility and 
acceptability trial.  The primary outcomes for this study were the feasibility and acceptability 
of MI-CBT for alcohol use in BD with respect to recruitment, retention and feedback from 
participants. Secondary outcomes were frequency and severity of alcohol use, time to next 
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bipolar episode, mood symptoms, quality of life, social functioning and medication 
adherence. 
Methods 
Study Design  
 
A pragmatic rater-blind RCT comparing up to 20 sessions of integrated MI-CBT for alcohol 
use in BD compared with treatment as usual (TAU; determined by each participant’s 
responsible clinician, primarily medication and community mental health team support) was 
conducted across nine NHS Trusts in the North West of England. Randomisation was carried 
out by an independent Clinical Trials Unit (Manchester Academic Health Science Centre; 
CTU 9) using a computer generated stochastic allocation with randomly sized permuted 
blocks. Minimisation (an adaptive stratified sampling approach to minise imbalance between 
arms; Taves, 1974) was used with respect to gender, number of previous bipolar episodes 
(<12, 12 or more episodes; mania (including mixed episode), hypomania or depression), and 
Alcohol Use Disorders Identification Test score. . Clinical outcomes from psychological 
therapy are typically better for females (Burt & Rasgon, 2004), whilst better outcomes in BD 
have been linked to fewer previous episodes (Scott et al., 2007), and baseline AUDIT score 
predicts alcohol relapse (Farren et al., 2013). The trial is reported in accordance with the 
CONSORT guidelines for non-pharmacological trials (Schulz et al., 2010). The study was 
reviewed and approved by the UK NHS Ethics Committee process (REC ref: 10/H1014/75) 
and was pre-registered on the ISRCTN registry (ISRCTN14774583) with a published 
protocol (Jones et al., 2018). To maintain masking of allocation, research assistants (RAs) 
provided participant details to the trial coordinator at a separate site, who shared this with the 
clinical trials unit. The outcome of each allocation was then shared with the participant and, 
where appropriate, a trial clinician. RAs collecting outcome data were housed separately from 
clinicians and trial coordinator.  
Participants 
Recruitment took place from July 2011-June 2013 from NHS adult mental health services 
and advertised through voluntary organisations, local media, posters and leaflets distributed 
to both NHS and non-NHS sites to maximise participant access. Potential participants 
indicated their interest in the study either through their service providers or contacting the 
research team directly to arrange a screening appointment. Inclusion criteria were: Age 18 
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years or over; Structured Clinical Interview for Diagnostic and Statistical Manual IV 
diagnosis of BD I or II (SCID DSM-IV: First et al., 1997); alcohol use exceeding 21 units for 
males/14 units for females on at least half of the weeks of the previous three months, or at 
least one alcohol 'binge' (exceeding UK Government recommended number of units of 
alcohol in a day; six units daily for men, four units daily for women (NICE, 2012)) per 
fortnight in each of the previous three months; Score of eight or more on the Alcohol Use 
Disorders Identification Test (AUDIT; Saunders et al., 1993); ability to provide informed 
consent and having a fixed abode.  
Procedures 
Following written informed consent obtained at a face-to-face visit by an RA at the 
participants’ preferred location (usually their home), diagnostic and alcohol use eligibility 
were confirmed using the SCID-IV and AUDIT respectively. Eligible participants completed 
baseline assessment measures prior to randomisation to MI- CBT plus TAU, or TAU only.  
Intervention 
The MI-CBT is a manualised intervention consisting of MI and CBT elements and was 
adapted from a treatment programme originally developed for people with substance abuse 
and psychosis (Barrowclough et al., 2001; adapted manual available from authors). 
Participants in the therapy arm were offered up to 20 individual; therapy sessions over six 
months. Sessions were typically 45 to 60 minutes long. Therapy was delivered at 
participants’ preferred location, usually their home consistent with the original protocol 
developed by Barrowclough et al (2001). This was consistent with the intention to offer a 
flexible and assertive approach to engagement of participants with potentially low motivation 
to change at recruitment. NHS services in the region in which the trial took place also offer 
home visits to engage complex hard to reach clients in care, Sessions were conducted 
individually without other family members present (where family members were in the house 
at the time they agreed to give the participant privacy for the session). . All therapists met the 
British Association of Behavioural and Cognitive Psychotherapies accreditation criteria and 
to further ensure therapist fidelity and competence were provided with a comprehensive 
three-month training period and additional weekly supervision sessions with supervisors 
experienced in both MI and CBT.  
MI-CBT was informed by a prior successful case series (Jones et al., 2011) and refined based 
on feedback from focus groups held with service users with lived experience of BD and 
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alcohol use and healthcare professionals. Initial sessions focused on engagement, employing 
MI to develop a shared understanding of the client’s key life goals and concerns, to elicit and 
selectively reinforce the client’s own self-motivational statements, and to monitor the client’s 
readiness to reduce their drinking. Therapist and client then worked to develop a shared 
understanding of how goals and concerns, and particularly how bipolar-relevant symptoms 
and relapses (depression, hypomania, anger, irritability, impulsiveness and disrupted social 
rhythms), were related to alcohol use. The formulation was used to identify individual 
determinants and consequences of the client’s key problems.  Where motivation for change 
was achieved, the next stage of therapy involved developing an alcohol reduction/abstinence 
plan guided by the individual formulation and by the needs of the client drawing on evidence 
based cognitive behavioural strategies. This phase also included CBT to facilitate alternative 
approaches to dealing with mood symptoms associated with alcohol use where appropriate. 
The intervention also included development of a relapse prevention plan that summarised 
learning from therapy and provided a reference for the client following completion of 
treatment. For those not ready to change alcohol use, the therapist worked on other client-led 
problems to maintain engagement whilst continuing to link alcohol use to their concerns 
through MI techniques. TAU for both groups typically consisted of routine medication (mood 
stabilisers, antipsychotics and antidepressants) and maintenances predominantly from 
secondary care services (community mental health team and psychiatrist appointments).   
Training and monitoring of trial therapists 
Four therapists (RH, KB, MF, IW) were employed and trained to deliver the MI-CBT 
intervention by CB and SJ. Therapists received group supervision fortnightly, including peer 
supervision and supervision led by CB. Therapists also had access to attend monthly joint 
sessions with SJ to discuss CBT-related issues.   
Screening measure 
 The Alcohol Use Disorders Identification Test (AUDIT; Saunders et al., 1993) was used as a 
screening tool to ensure all participants were experiencing problematic drinking at inception.  
Medium alcohol problems were reflected in a score of 8-15, whilst High to severe alcohol 
problems were indicated by AUDIT score of  >= 16. 
Assessment of outcomes 
RAs (EW, LB, HR), blind to treatment allocation, conducted outcome assessments for all 
available participants at baseline, 3-, 6- (end of therapy), 9- and 12-month follow-up (see 
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Table 1). All assessments were administered in person, at participants’ preferred location 
(usually their home), and recorded with consent from the participant. Any unblindings were 
recorded and an alternative, blind RA carried out further assessments.  
Primary Feasibility and Acceptability Outcomes 
Feasibility and acceptability were evaluated in terms of levels of recruitment into the trial, 
retention of participants in both arms of the study, and treatment fidelity assessed by the MI-
CBT Fidelity Scale (Haddock et al., 2012) adapted for the current study. Scores were 
recorded for Section A (adherence with procedure) and Section B (appropriate and strategic 
use of core skills). Therapeutic alliance (Work Alliance Inventory, WAI-S; Tracey & 
Kokotovic, 1989 client and therapist) and therapy attendance and client evaluation were also 
recorded.  
 
A nested qualitative study was conducted with 15 participants purposively sampled on 
number of sessions attended, age, sex, number of relapses, level of alcohol use and outcomes 
to explore participants’ experiences of the MI-CBT intervention. Participants were asked 
about their prior experience of therapy, their expectations of the current intervention and its 
timing, their views on therapy sessions and any homework, whether the intervention seemed 
to address mood and alcohol issues, relevance to their health issues, how they would describe 
the intervention, how it compared to prior therapy experiences in terms of session location 
and duration.  
 
Clinical outcomes   
Primary clinical outcomes were frequency and severity of alcohol use (Time Line Follow 
Back Interview (TLFB; Sobell & Sobell, 1992)) and time to next bipolar episode (SCID Life; 
Keller et al., 1987).  
Additional outcomes were: 
 Observer-rated mood symptoms (Hamilton Depression Rating Scale; HAM-D; 
Hamilton, 1960 and Bech-Rafaelsen Mania Scale;MAS; Bech et al., 1978)  
 Self-reported mood symptoms(Patient Health Questionnaire–9; PHQ-9; Kroenke et 
al., 2001 and Internal States Scale;ISS; Bauer et al., 1991) 
 Quality of life and social functioning (Personal and Social Performance Scale; PSP; 
Morosini et al., 2000) 
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 Medication adherence (Stephenson Medication Adherence Interview; MEDAD; 
Stephenson et al., 1993). 
The Readiness for Change Questionnaire (Rollnick et al., 1992) was employed to evaluate the 
extent to which progression through stages of change (Prochaska & DiClemente, 1986) (pre-
contemplation, contemplation, preparation and action) was associated with clinical outcomes. 
Data Analysis  
As the primary purpose of the study was to evaluate the feasibility and acceptability of 
delivering the integrated MI-CBT intervention, a formal power calculation was not 
appropriate. It was estimated that 24 participants per group would be sufficient to be able to 
reliably determine primary feasibility outcome allowing a 50% recruitment rate to be 
estimated with precision +/- 15% (95% confidence intervals) and a 70% rate of study 
retention estimated with precision +/-20% (95% confidence intervals) consistent with 
guidance to clearly articulate feasibility study requirements  (Lancaster et al., 2004).  
Primary outcomes were percentage of participants randomised relative to those referred, 
percentage of participants completing outcome data, percentage retention to both arms, mean 
session attendance, therapist adherence to therapy protocol (percentage per session), mean 
therapeutic alliance, and percentage readiness for change at baseline and end of intervention 
The study was not powered to evaluate the effectiveness of clinical outcomes but may help 
inform estimates of the potential treatment effect sizes (secondary objective).  
For the time to relapse analysis, a Cox model was fitted with treatment arm, gender, number 
of previous bipolar episodes (<12 vs 12 or more) and AUDIT score at randomisation (8 to 15 
versus 16 or more) as covariates. 
Repeated measures models with discrete time were fitted to the TLFB data. In Model 1 (M1) 
a discrete time by treatment interaction was fitted to estimate the treatment effect and the 
95% confidence interval at each follow-up time point. If there was no evidence of an 
interaction at the 5% level then the interaction term was omitted and the overall treatment 
effect was estimated (model M2).  The same covariates as described above were used for 
these models, except that the AUDIT score was replaced with the baseline value of the 
outcome. Summary means and standard deviations by group and assessment point are 
provided for other clinical and process measures. Additional outcomes are summarised by 
descriptive statistics by treatment arm and assessment point  
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Qualitative interviews were audio-recorded, transcribed verbatim and thematically analysed 
from a realist perspective to explore participants’ experiences of MI-CBT (Braun & Clarke, 
2006). Themes were compared against the data using a constant comparative approach by a 
multidisciplinary panel (CH, SP, LR, SJ, CB, RL). Interviews were conducted until thematic 
saturation was achieved 
Results 
Participant Characteristics  
Participants were on average over 40 years old (MI-CBT = 41.3, SD = 13.1; TAU = 42.1, SD 
= 10.4) and most were male (52%) with a chronic relapsing course of BD and harmful 
alcohol use (Audit 16 or more; Table 2).  The large majority were white British (>90%) and 
divorced or never married (>80%), with just under half having no children (48%). Although 
over 60% of participants had at least begun further or higher education, 75% were currently 
unemployed and only 8% were in full-time employment. SCID interviews indicated that 
participants predominantly had bipolar 1 disorder (91%), with high rates of lifetime alcohol 
abuse (73%) and dependence (62%). Consistent with the focus of the MI-CBT trial, lifetime 
rates of other substance use were lower (18% abuse; 27% dependence) 
Baseline level of mean daily alcohol consumption was in the high-risk range for the MI-CBT 
arm and on the threshold for high risk in the TAU arm, with frequency of use and frequency 
of binge days also elevated in comparison to the general UK and EU population in both arms 
(Rehm et al., 2012) (see Table 3). This pattern suggests that the selection criterion based on 
AUDIT has appropriately identified participants with problematic patterns of drinking. 
Depressed mood was at normal levels on HAM-D and mania scores were low on MAS 
(Online Table 1). In terms of readiness for change, the sample were predominantly at the pre-
contemplation or contemplation stages indicating that we recruited participants who were 
potentially ambivalent about change in their alcohol use, whilst levels of impulsivity were 
similar at baseline to those observed in previous research with individuals with BD and 
comorbid substance use (Swann et al., 2004)  (Online Tables 2-3).  MEDAD scores indicated 
high medication adherence overall. Three participants were not taking any medication at 
baseline, the remainder were receiving a variety of medication (antidepressant, mood 
stabilising, benzodiazepine, antipsychotic) with different numbers of participants receiving 
each medication type. Across medication types very few days’ medication were missed, with 
mean higher adherence (fewer days missed) in TAU (Online Table 4).  
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Primary Feasibility Outcomes  
Figure 1 presents recruitment and retention rates for participants in the MI CBT and TAU 
arms respectively, consistent with CONSORT criteria. Seventy-six potentially eligible 
participants were referred to the study over a period of 23 months. Two people could not be 
contacted for further assessment and 30 were excluded as they did not meet eligibility criteria 
at pre-screen (n = 22) or declined to participate (n = 8). Thus, only 10.5% of those offered the 
opportunity to participate in the trial declined.   
Forty-four participants were randomised, 58% of those originally referred (92% of the target 
figure of 48). Primary clinical outcome data (SCID DSM-IV: SCID Life and TLFB) was 
collected for 39 (89%) participants at 3 months, 33 (75%) at 6 months, 32 (73%) at 9 months 
and 33 (75%) at 12 months. Retention for treatment arm was 79% to 12 months and 70% for 
TAU respectively. There was no evidence for differential retention at any of the follow-up 
points by arm (p > 0.25 for all Χ2 comparisons).  
Unblindings 
Single unblindings were reported for 8 MI-CBT and 2 TAU participants. One unrelated 
adverse event was recorded, in which an MI-CBT participant took an overdose of medication, 
sought and received primary care help and was resolved without hospitalisation. 
Treatment delivered and treatment fidelity 
All of the 24 participants allocated to therapy arm attend at least one therapy session. Mean 
session attendance was 17.6 (SD = 4.5) with 21/24 attending at least 15 of 20 possible 
sessions. Proportions of participants attending sessions from 0-20 are as follows: 1-5 = 1 
(4.2%), 6-10 = 1 (4.2%), 11-15 = 1 (4.2%), 16-20 = 21(87.5%). 
 
Adherence to MI-CBT approach was independently assessed on the  MI-CBT Fidelity Scale 
for 9 sessions elected across early to late stages of therapy (sessions 4-16).  Adherence and 
fidelity were at least adequate for 8/9 (88.9%) of recordings.  
Therapeutic alliance was assessed after session 3 and session 16. At session 3, there were 19 
client WAI ratings (mean 63.74, SD 9.12) at session 16 and 17 ratings (mean 65.05, SD 
6.50). For therapist rated WAIs there were 22 ratings (mean 59.09, SD 9.76) at session 3 and 
19 ratings (mean 62.31, SD 10.54) at session 16. 
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Readiness to change score indicated increases in proportion of participants in MI-CBT 
moving to action phase (n=2, 8.7% baseline; n=10, 58.8% 12 month follow-up) compared to 
TAU (n=5, 25% baseline; n=4, 33.3% 12 month follow-up; Online Table 2) although this was 
not statistically significant (χ2 = 3.5, p = 0.062) . There was no evidence for differential 
changes in impulsivity or medication adherence by treatment arm over time (Online Tables 3-
4). 
 
Qualitative data on Acceptability 
 Participants who engaged with qualitative interviews were mainly bipolar 1, male (n=10), 
middle aged (mean 44.53, SD 13.82) and had attended 15-20 therapy sessions (see table 4) 
 
(See Table 5 for illustrative quotes) 
Participants indicated the MI-CBT intervention was helpful in addressing behaviours they 
identified as harmful and despite their concerns in advance of treatment, was experienced as 
collaborative rather than directive. It is of note that prior concerns reported included how 
services might respond if honest about current consumption, which led some participants to 
say that they had not done so at baseline. The MI-CBT approach facilitated engagement and 
sense of personal control and responsibility over the decisions made in treatment. Participants 
indicated that they became less likely to find alcohol use being triggered by stress or social 
events and that they were better able to cope with bipolar mood symptoms and improve 
functioning. Participants who had felt unable to be honest about their alcohol use at baseline 
reported therapy helped them develop strategies to reduce their drinking. In contrast to these 
positive comments, one participant experienced the intervention as more conversational than 
therapeutic and another felt that after gaining confidence in therapy they felt they tried to do 
too much during a period of elevated mood and then felt overloaded. 
Secondary Outcomes  
Key exploratory clinical outcomes for the MI-CBT study were frequency and quantity of 
alcohol use (see Table 3 & 6) and time to next bipolar recurrence (see Figure 2).  
Alchohol Data - TLFB 
Mean alcohol use and percentage binge days reduced, and percentage days abstinent 
increased from baseline in both arms. Table 5 shows the results from fitting repeated 
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measures models to these outcomes. None of the time by treatment interactions were 
significant but the overall treatment effect was significant for percentage days abstinent from 
alcohol (an estimated 12 % days lower on MI-CBT compared to TAU, P=0.04). 
Episode recurrence 
Thirty-seven percent (n=9) of MI-CBT and 25% (n=5) of TAU participants had a recurrence 
of depression (n=7 in MI-CBT and n=5 in TAU) or mania (n=2 in MI-CBT) during follow-
up: a non-significant difference (hazard ratio 1.50, 95% CI, 0.49 to 4.58, P = 0.478). Kaplan-
Meier plot for time to first recurrence among the two groups is shown in Figure 2.   
Additional exploratory Self- and observer-rated outcome measures 
Social functioning (PSP) remained within the same functioning categories for both arms 
across follow-up (Online Table 5).  Mood states remained similar over the follow-up period 
in both arms as indicated by ISS (Bauer et al, 2000), except for a reduction in those in 
euthymia in TAU at 6 months and higher rates of mixed states at 12 months in both arms 
compared to baseline (Online Table 6). PHQ-9 scores indicated low rates of moderate to 
severe depression throughout, with reductions in the MI-CBT arm at follow-up (Online Table 
7). Observer rated depression (HAM-D) and mania (MAS) remained in the normal range 
throughout (Online Table 1).  
Discussion 
This paper reports the first RCT feasibility and acceptability study of a new integrated 
psychological intervention for alcohol use issues in the context of BD. Trial design appears to 
be feasible with recruitment 92% of target and only 10.5% of those offered the opportunity to 
participate refusing.  Of 76 individuals screened, 58% both met inclusion criteria and agreed 
to participate, an inclusion rate that is higher than previous individual CBT for bipolar 
disorder trials (Jones et al., 2015; Lam et al., 2003; Scott et al., 2006) and comparable with 
integrated group therapy interventions for substance use and BD (47-59%) (Weiss et al., 
2007; 2009).  
Retention to 12-months follow-up was 75%, and did not differ significantly between arms, 
suggesting that resentful demoralisation was not a significant issue for the TAU arm of this 
trial (Brewin & Bradley, 1989). This retention rate is similar to that reported for in-person 
data collection by Weiss et al. 2007/2009 (73.8-74.2%) but lower than their total retention to 
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follow-up when second tier data collection (95%: email/questionnaire) was included. It is 
likely that this is due to differences in inclusion criteria (current trial permitted inclusion of 
individuals not reporting high motivation to change or adherence to mood stabiliser 
medication) and longer follow up period (12 months from baseline compared with 6-8 
months).  Consistent with this, these retention rates compared favourably with the with other 
CBT trials for BD with comparable follow up periods (Jones et al., 2015; Scott et al., 2006).  
Demographic characteristics of participants in the current trial were similar to those in the 
majority of RCT evaluations of psychological therapy for BD to date. Participants were 
predominantly over 40 years old, with a chronic course of BD and unemployed, despite most 
having education beyond GCSE level (Jones et al., 2015; Meyer & Hautzinger, 2012; Scott et 
al., 2006).  We are not aware of any previous individual psychological therapy trials that have 
focussed specifically on alcohol use in BD, so there is no direct comparator with respect to 
severity of alcohol use. However, AUDIT scores for the current study indicated the majority 
of participants fell into the category of harmful/hazardous use; balance across arms was an 
issue here with 20% more falling into this category in MI-CBT compared with TAU at 
baseline. 
The current trial also indicated that delivery of MI-CBT intervention is feasible. No 
participants refused the intervention, with an average attendance of 88% of sessions offered. 
This is higher than group therapy attendance in the Weiss et al. (2007; 2009) trials (54-74%), 
despite their exclusion of participants without confirmed motivation to change both substance 
use and bipolar symptoms.  In-depth qualitative interviews with recipients of the MI-CBT 
intervention indicated that the intervention was positively received, with engagement 
enhanced by the collaborative flexible approach fundamental to MI and reports of meaningful 
improvements in alcohol use, mood, self-management and functioning including reengaging 
with work. Not all experiences were positive, however, including perception of sessions as 
‘nice’ but not formal therapy and that confidence imbued through progress in therapy could 
interact with mood elevation and lead to over activity. This latter perception contrasts with 
reports of effective self-management strategies. Overall, these findings might suggest that 
additional provision of booster sessions might help capitalise on gains in self-management 
whilst mitigating potential risks linked to over-confidence.   
As a feasibility and acceptability study, this was not designed to formally test the efficacy of 
MI-CBT in changing clinical outcomes. Therefore, although information was collected with 
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respect to alcohol use, mood, relapse and functioning, any estimates were imprecise.  No 
significant differences were observed across groups with respect to mean alcohol use or 
percentage of binge days; in both cases, there was a pattern of general reduction in both arms. 
Number of days abstinent from alcohol increased in both arms. It is of note here that the 
focus of the MI-CBT intervention was based on collaborative goals around reduction and 
management of alcohol rather than eradication of use.   
Overall, recurrence rate for episodes of mania or depression was approximately 31%, which 
is extremely low compared with previous individual therapy trials for BD (52-53% over 48-
72 weeks; Lam et al., 2003; Scott et al., 2006) and did not significantly differ between arms. 
Very low levels of depression and mania at baseline may have influenced the recurrence rate 
observed.  
Despite significant levels of risk in relation to alcohol consumption, the participants reported 
generally good social functioning and low levels of depression and mania symptoms at 
baseline. This pattern remained similar across the follow up period and did not differ 
significantly between groups.  
Gold et al. (2018) indicated that of the 8 trials included in their review, only those of Weiss 
and colleagues (2007; 2009) showed consistent evidence of benefit in relation to substance 
use outcomes (and none showed consistent benefits for both mood and substance use. 
Compared with Weiss et al.’s (2007; 2009) studies of integrated group therapy, the current 
trial did not signal a benefit in relation to alcohol outcomes despite better attendance rates at 
therapy and high levels of satisfaction with therapy as indicated by qualitative interviews. As 
noted above, the current trial did not require participants to be taking a mood stabiliser or be 
actively seeking treatment for both substance and bipolar mood issues, in contrast to Weiss et 
al.’s (2007; 2009) studies. Other differences with respect to participants were that for the 
current study the majority of the participants were male, unemployed, and had lower rates of 
alcohol abstinence days (39% of days in previous month vs 66-72%) and much lower levels 
of depression and mania at baseline.. It would therefore be of interest to explore the extent to 
which integrated group therapy is of benefit to a less selected sample delivered outside a 
specialist treatment centre. With respect to the current MI-CBT intervention it appears that 
the intervention was feasible and acceptable and successfully engaged participants. However, 
it is possible that improved clinical outcomes might require further adaptation of the therapy 
including consideration of whether the intervention was of sufficient duration to address the 
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complexity of participants’ longstanding problems. It would also be worth considering 
whether the promising findings in relation to acceptance and commitment approaches for 
smoking behaviour in BD (Heffner et al., 2013; 2015) might enhance the current approach by 
increasing willingness to experience discomfort to achieve personally valued change in 
behaviour.  
There were some limitations to the current study. Sample size was selected to permit 
assessment of feasibility and acceptability outcomes for this trial and was not powered to test 
clinical outcomes.  Therefore, findings with respect to clinical outcomes should be treated 
with caution. Measures of alcohol consumption were self-report/interview rather than through 
objective monitoring, which means that actual levels of use could not be formally validated. 
However previous research suggested high concordance between self-report and objective 
screening (Weiss et al., 2007). The overwhelming majority of participants had bipolar I so it 
is unclear how the current results relate to other subtypes of BD. 
Strengths of the study include comprehensive assessment of participants, extended follow-up 
assessment from baselines and the evaluation of outcomes from both quantitative and 
qualitative perspectives.   
Conclusion  
Feasibility and acceptability of selection, recruitment and intervention procedures was 
demonstrated for the trial. Participants engaged with therapy when offered, and retention to 
follow-up was acceptable. Participants had significant levels of alcohol use problems at 
baseline but appeared to be comparatively well in terms of mood symptoms and social 
functioning. None of these outcomes changed differentially in the treatment group. The lack 
of change in some of these outcomes is likely to be associated with floor effects. Further 
investigation is required to identify how this intervention can be adapted to enhance clinical 
outcomes so that it efficacy matches the positive feasibility and acceptability data. 
Trial Registration  
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Figure 1. Study CONSORT diagram 




Table 1. Schedule of Assessments  
 
Assessment Baseline 3 months 6 months 9 months 12 months 
Primary Outcome Measures      
Time Line Follow Back            
SCID Life           
Secondary Outcome Measures      
Hamilton Depression Rating 
Scale 
          
Bech-Rafaelsen Mania Scale           
Internal State Scale         
Personal and Social Performance 
Scale 
        
Stephenson Medication 
Adherence Interview 
        
Euroquol Scale         
Patient Health Questionnaire,          
State-Trait Anxiety Inventory for 
Adults 
        
Barratt Impulsiveness Scale         
Readiness to change 
questionnaire - Alcohol 





Table 2. Baseline demographic and clinical characteristics 
 
Characteristic MI-CBT (n = 24), 
No. (%) 
TAU (n = 20), No. 
(%) 
Sex   
Male 14 (58.3)  9 (45.0)  
Female 10 (41.7) 11 (55.0) 
Previous episodes   
<12 9 (37.5)  8 (40.0)  
12 or more 15 (62.5) 12 (60.0) 
AUDIT score   
8-15 8 (33.3)  11 (55.0)  
16 or more 16 (66.7) 9 (45.0) 
Ethnicity    
White British 24 (100.0) 16 (80.0)  
Other white 0 1 (5.0)  
Black British 0 2 (10.0)  
Asian  0 1 (5.0) 
Marital status    
Divorced/annulled/separated 8 (33.3) 6 (30.0) 
Never married 11 (45.8) 11 (55.0) 
Married or cohabiting 5 (20.8) 3 (15.0) 
Number of children    
0 11 (45.8) 10 (50.0) 
1 5 (20.8) 7 (35.0) 
2 2 (8.3) 3 (15.0) 
3 5 (20.8) 0  
Not stated 1 (4.2) 0 
Education   
Year 7-11 (No GCSEs) 4 (17.4) 2 (10.0) 
GCSEs or equivalent 4 (17.4) 7 (35.0) 
Further education not 
completed 
1 (4.3) 2 (10.0) 
Further education completed 4 (17.4) 2 (10.0) 
Higher education not 
completed 
2 (8.7) 1 (5.0) 
Higher education completed 5 (21.7) 3 (15.0) 
Postgraduate not completed 2 (8.7) 1 (5.0) 
Postgraduate completed 1 (4.3) 2 (10.0) 
Working   
No 17 (70.8)  16 (80.0)  
Yes (includes 1 volunteer) 7 (29.2) 4 (20.0) 
Type of work    
Employed full-time 2 (8.3) 2 (10.0) 
Employed part-time 3 (12.5) 0 
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Voluntary 0 1 (5.0) 
Self employed 1 (4.2) 1 (5.0)  
Unemployed 3 (12.5) 1 (5.0) 
Sick/disability 11 (45.8) 12 (60.0) 
Retired 2 (8.3) 1 (5.0) 
Student 1 (4.2) 2 (10.0) 
Not stated 1 (4.2) 0 
Bipolar Status   
Bipolar I 21 (87.5) 19 (95.0) 
Bipolar II 3 (12.5) 1 (5.0) 
Alcohol abuse   
Overall 20 (83.3) 12 (60.0) 
In the past month 11 (55.0) 7 (58.3) 
Alcohol Dependence   
Overall 15 (62.5) 12 (60.0) 
In the past month 7 (46.7) 7 (58.3) 
Substance Abuse   
Overall 4 (16.7) 4 (20.0) 
In the past month 0 1 (25.0) 
Substance Dependence   
In the last 12 months 8 (33.3) 4 (20.0) 





Table 3. Summary statistics on frequency of alcohol use (timeline follow back) over 30 days 
  MI-CBT TAU 
Visit 
(months) a  M SD n M SD n 
  Mean Alcohol units/day 
0 7.5 5.3 24 6.0 3.5 20 
3 7.4 7.8 22 5.5 4.3 17 
6 6.1 4.8 19 4.1 3.6 14 
9 6.5 5.7 18 4.1 4.6 14 
12 5.7 5.5 19 4.2 4.1 14 
 % days abstinent alcohol 
0 39.3 26.3 24 43.3 24.0 20 
3 45.2 32.0 22 48.2 30.1 17 
6 45.8 33.7 19 60.2 31.1 14 
9 41.3 37.7 18 62.1 30.6 14 
12 47.4 35.0 19 61.7 23.3 14 
 % binge days 
0 48.3 3.4 24 43.9 28.6 20 
3 43.5 32.6 22 41.6 36.3 17 
6 41.4 34.7 19 30.5 31.3 14 
9 42.0 39.0 18 30.7 34.1 14 






Table 4. Demographic and clinical characteristics of qualitative interviewees 
Pt. No.   Sex  Age   Employment status  Bipolar Status  No. of sessions attended 
AB001  M  30  working  Bipolar 1  20 
AB002  M  28  Unemployed  Bipolar 1  20 
AB003  F  47  Unemployed  Bipolar 1  19 
AB004  F  49  Unemployed  Bipolar 1  20 
AB005  M  66  Retired  Bipolar 1  18 
AB006  M  31  Unemployed  Bipolar 1  20 
AB007  M  24  Unemployed  Bipolar 2  20 
AB008  M  52  Unemployed  Bipolar 1  20 
AB009  M  54  Unemployed  Bipolar 1  20 
30 
 
AB010  F  37  Working  Bipolar 1  18 
AB011  M  67  Retired  Bipolar 1  16 
AB012  F  58  Working  Bipolar 1  20 
AB013  M  52  Retired  Bipolar 1  15 
AB014  M  40  Working  Bipolar 1  19 




Table 5. Illustrative quotes from qualitative interviews with MI-CBT participants  
 
 
Theme Illustrative Quotes  
Helpfulness of intervention overall  ‘The fact that it's worked, and it has 
worked for somebody who well self-
confessed is really, really cut up, 
messed up, scarred like you know I 
was totally destroying myself, and 
the fact that it has managed to work 
on someone like me’ (AB002) 
‘The therapy without wanting to 
sound melodramatic I would 
probably say it was fairly life 
changing for me to be honest.’ 
(AB001) 
 
Pre-therapy concern about being told what 
to do  
“I had actually lied to the researchers; I 
had scaled down how much I was 
drinking. I had lied because of I thought 
because I am a single parent, and my 
son is everything to me, and I was 
really, really worried about the 
implications of admitted how much I 
was drinking.”  AB003 
 ‘I was worried… that it was going 
to be like, writing thou shalt not 
drink, I thought it was going to be a 
bit of a finger wagging erm... 
because I can't give up alcohol, I 
can't, because by giving up alcohol I 
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would give up my whole social 
existence.’  (AB008) 
‘There is probably elements of 
things that we didn’t cover, not 
necessarily because there wasn’t 
time but because I didn’t want to 
cover them at that time. Erm… I 
think [therapist] touched on a 
couple of things that, quite 
emotional things for me, erm… as I 
was growing up and things like, that 
we didn’t touch on because I found it 
too stressful at the time.’ (AB010) 
 
Engagement with MI-CBT ‘[Therapist] never came across as 
superior so to speak or anything like 
that it was like on a one-to-one 
equal basis. And I never felt put 
down by saying certain, you know 
things other people might find 
stupid, hearing things and things 
like that it wasn’t ever; I didn’t feel 
embarrassed to say anything 
whatever.’ (AB010) 
‘The biggest thing that I became 
aware of, out of all the therapy and 
speaking to you and everything, 
everybody who has ever come and 
seen me, it is down to me, it is down 
to me, it is not about the people who 
come and sit and you discuss it with 
them who were really kind to me and 
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what have you it's not at the end of 
the day the buck stops with me.’ 
(AB008) 
 
Benefits in relation to alcohol and mood “the therapy really took off, and I was able 
to put into place plans to make changes to 
my drinking from the therapy and it was 
excellent at that. I am so glad I have gone 
through the process, I have even made my 
own file and plan of action, of how I was 
going to cut down, cut down on my 
drinking.”  (AB003) 
 
‘I feel it’s much more manageable it is not 
my go-to place, so it is not the first thing 
that I go right I need a drink… because 
always there is a reason to drink, there is a 
funeral, there is a wedding, you are happy, 
you are sad, you are stressed you are on 
holiday, you could link it as much as you 
want to, erm… so I feel that I have 
extricated myself from [that].’  (AB015) 
‘I have been great. I have not had any 
erm... more episodes and I have stayed 
out of hospital, and I have started a little 
job actually.’  (AB006) 
‘having a one-to-one and feel that it's safe 
to talk, about your problems, well made 
me, give me the courage a bit, to go 
forward rather than backwards’  (AB009) 
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‘[my daughter] understands how I feel 
now rather than just mom is not well 
today, erm… she understands it, she even 
jokes about it now.’ (AB010) 
 
Negative comments on MI-CBT  I couldn’t actually say that you know 
I felt it was therapeutic. The 
conversation was therapeutic 
because it’s always nice to be 
involved in a conversation but you 
know apart from that you know I 
couldn’t say it was a therapy.’ 
(AB011) 
‘as time went on and what I had set 
out to do I had achieved, I actually 
started to get overconfident, and 
then towards the end of the therapy I 
was going a bit up and trying to do 
too much so I got ahead of myself, 
and that ended up with me just 
overloading myself and then hitting 





Table 6. Repeated measures model analyses for the TLFB outcomes 








Mean Alcohol/day       
Model 1 3 0.98 -2.04 4.00  
 6 0.92 -1.15 3.00  
 8 0.72 -1.38 2.82  
 12 0.06 -2.96 3.09  
time*treatment interaction     0.955 
linear trend test     0.641 
Model 2 - no interaction  0.68 -0.77 2.14 0.358 
% days abstinent alcohol       
Model 1 3 -5.39 -21.5 10.7  
 6 -16.0 -32.1 0.12  
 9 -16.7 -36.3  2.89    
 12 -14.9 -31.6  1.81  
time*treatment interaction     0.500 
linear trend test     0.395 
Model 2 - no interaction  -12.0 -23.5 -0.48 0.041 
% days abstinent all substances       
Model 1 3 0.77 -15.3 16.8  
 6 -15.1 -31.1 0.90  
 9 -15.7 -34.9 3.41  
 12 -10.2 -26.5 6.14  
time*treatment interaction     0.226 
linear trend test     0.335 
Model 2 - no interaction  -9.0 -19.8 1.87 0.105 
% binge days        
Model 1 3 -0.46 (-14.5 13.6)  
 6 7.55 (-4.80 19.9)  
 9 1.86 -15.2 19.0  
 12 -1.78 -19.5 16.0  
time*treatment interaction     0.569 
linear trend test     0.775 
Model 2 - no interaction  2.16 -6.93 11.26 0.641 
 
 
 
 
